Skip to main content

Animations

MJFF Publications

3881 - 3890 of 9140 Results
Title
Year
  • Year
  • 2014
  • 2016
  • 2014
  • 2014
  • 2018
  • 2017
  • 2018
  • 2017
  • 2017
  • 2017
  • Summary Details
    OPEN
    Title: Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic Calcium Signaling in Astrocytes
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0110996
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-016-0665-5
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0109042
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0108982
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting
    Journal Name: EJNMMI Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13550-018-0393-5
    Citation Count: 11
  • Summary Details
    OPEN
    Title: A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-017-01103-4
    Citation Count: 463
  • Summary Details
    OPEN
    Title: NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0061-5
    Citation Count: 188
  • Summary Details
    OPEN
    Title: Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
    Journal Name: Journal of Clinical Movement Disorders
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40734-017-0051-5
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Neuropathological and transcriptomic characteristics of the aged brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.31126
    Citation Count: 141
  • Summary Details
    OPEN
    Title: Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0492-y
    Citation Count: 89
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.